Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6206)
All Articles published online
|
Publishing Process of This Article
|
Dec 27, 2020 (publication date) through Jul 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yokoo H, Takahashi H, Hagiwara M, Iwata H, Imai K, Saito Y, Matsuno N, Furukawa H. Successful hepatic resection for recurrent hepatocellular carcinoma after lenvatinib treatment: A case report. World J Hepatol 2020; 12(12): 1349-1357 [PMID: 33442460 DOI: 10.4254/wjh.v12.i12.1349] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v12/i12/1349.htm |
| Number | Citing Articles |
| 1 |
Yoshifumi Hidaka, Miyo Tomita, Ryosuke Desaki, Masahiro Hamanoue, Sonshin Takao, Mari Kirishima, Takao Ohtsuka. Conversion surgery for hepatocellular carcinoma with portal vein tumor thrombus after successful atezolizumab plus bevacizumab therapy: a case report. World Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02691-2
|
| 2 |
Yutaka Endo, Motohide Shimazu, Tadayuki Sakuragawa, Yusuke Uchi, Motonori Edanami, Ken Sunamura, Soji Ozawa, Naokazu Chiba, Shigeyuki Kawachi. Successful treatment with laparoscopic surgery and sequential multikinase inhibitor therapy for hepatocellular carcinoma: A case report. World Journal of Gastrointestinal Surgery 2022; 14(3): 260-267 doi: 10.4240/wjgs.v14.i3.260
|
| 3 |
Yuta Tai, Yoshifumi Morita, Mitsumasa Makino, Shinya Ida, Ryuta Muraki, Ryo Kitajima, Makoto Takeda, Hirotoshi Kikuchi, Yoshihiro Hiramatsu, Hiroya Takeuchi. A Case of Giant Hepatocellular Carcinoma Successfully Treated with Lenvatinib Followed by Parenchymal-Sparing Hepatectomy. The Japanese Journal of Gastroenterological Surgery 2023; 56(10): 547 doi: 10.5833/jjgs.2022.0104
|
| 4 |
Yoh Asahi, Toshiya Kamiyama, Tatsuhiko Kakisaka, Tatsuya Orimo, Shingo Shimada, Akihisa Nagatsu, Takeshi Aiyama, Yuzuru Sakamoto, Hirofumi Kamachi, Akinobu Taketomi. Outcomes of reduction hepatectomy combined with postoperative multidisciplinary therapy for advanced hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2021; 13(10): 1245-1257 doi: 10.4240/wjgs.v13.i10.1245
|
| 5 |
Kensuke Yamamura, Toru Beppu. Conversion surgery for hepatocellular carcinoma after multidisciplinary treatment including lenvatinib. Hepatology Research 2021; 51(10): 1029 doi: 10.1111/hepr.13691
|
| 6 |
Junichi Arita, Akihiko Ichida, Rihito Nagata, Yuichiro Mihara, Yoshikuni Kawaguchi, Takeaki Ishizawa, Nobuhisa Akamatsu, Junichi Kaneko, Kiyoshi Hasegawa. Conversion surgery after preoperative therapy for advanced hepatocellular carcinoma in the era of molecular targeted therapy and immune checkpoint inhibitors. Journal of Hepato-Biliary-Pancreatic Sciences 2022; 29(7): 732 doi: 10.1002/jhbp.1135
|
| 7 |
Yu Gyoda, Hirofumi Ichida, Fumihiro Kawano, Yoshinori Takeda, Ryuji Yoshioka, Hiroshi Imamura, Yoshihiro Mise, Yuki Fukumura, Akio Saiura. A patient alive without disease 32 months after conversion surgery following lenvatinib treatment for hepatocellular carcinoma with a tumor thrombus originating in the middle hepatic vein and reaching the right atrium via the suprahepatic vena cava: a case report. Clinical Journal of Gastroenterology 2024; 17(2): 311 doi: 10.1007/s12328-023-01909-4
|
| 8 |
Junichi Shindoh, Yusuke Kawamura, Masahiro Kobayashi, Norio Akuta, Satoshi Okubo, Masaru Matsumura, Yoshiyuki Suzuki, Masaji Hashimoto. Prognostic Advantages of Individual Additional Interventions After Lenvatinib Therapy in Patients with Advanced Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery 2022; 26(8): 1637 doi: 10.1007/s11605-022-05388-9
|
| 9 |
Shunji Sano, Yoh Asahi, Toshiya Kamiyama, Tatsuhiko Kakisaka, Tatsuya Orimo, Akihisa Nagatsu, Takeshi Aiyama, Keizo Kazui, Hiroki Shomura, Shinya Ueki, Yuzuru Sakamoto, Chisato Shirakawa, Hirofumi Kamachi, Hirokazu Sugino, Tomoko Mitsuhashi, Akinobu Taketomi. Conversion surgery after lenvatinib treatment for multiple lung metastases from hepatocellular carcinoma. International Cancer Conference Journal 2022; 12(1): 7 doi: 10.1007/s13691-022-00567-6
|
| 10 |
Yoichiro Okubo, Soji Toda, Shinya Sato, Emi Yoshioka, Kyoko Ono, Chie Hasegawa, Kota Washimi, Tomoyuki Yokose, Yohei Miyagi, Hiroyuki Iwasaki, Hiroyuki Hayashi. Histological findings of thyroid cancer after lenvatinib therapy. Histopathology 2023; 83(4): 657 doi: 10.1111/his.15013
|
| 11 |
Atsushi Naganuma, Yuhei Suzuki, Takashi Hoshino, Hidetoshi Yasuoka, Yuki Tamura, Hiroaki Naruse, Hiroshi Tanaka, Keitaro Hirai, Ichiro Sakamoto, Tetsushi Ogawa, Takeshi Hatanaka, Satoru Kakizaki. A case of conversion hepatectomy for huge ruptured hepatocellular carcinoma after transarterial embolization and lenvatinib therapy. Clinical Journal of Gastroenterology 2022; 15(1): 177 doi: 10.1007/s12328-021-01558-5
|
| 12 |
Yu Ota, Kazunobu Aso, Hideki Yokoo, Mikihiro Fujiya. Noninvasive Visualization of Tumor Blood Vessels within Hepatocellular Carcinoma by Application of Superb Microvascular Imaging to Contrast-Enhanced Ultrasonography. Diagnostics 2024; 14(7): 678 doi: 10.3390/diagnostics14070678
|
| 13 |
Shinji Itoh, Katsuya Toshida, Kazutoyo Morita, Takeshi Kurihara, Yoshihiro Nagao, Takahiro Tomino, Takeo Toshima, Noboru Harada, Masaki Mori, Tomoharu Yoshizumi. Clinical effectiveness of surgical treatment after lenvatinib administration for hepatocellular carcinoma. International Journal of Clinical Oncology 2022; 27(11): 1725 doi: 10.1007/s10147-022-02229-2
|